{"record":{"code":"W-03025","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"BMY · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD","buyer":"","amount":36704958.8994,"currency":null,"records":8,"found":"2026-10-04","refs":["ocds-dgv273-seacev3-955379","ocds-dgv273-seacev3-1025335","ocds-dgv273-seacev3-1066853","ocds-dgv273-seacev3-955395","ocds-dgv273-seacev3-1221063","ocds-dgv273-seacev3-1220947","ocds-dgv273-seacev3-1157685","ocds-dgv273-seacev3-44891"],"id":"W-03025","html":"https://worldwide-corruption.com/record/peru/findings/fcpa-pattern/W-03025/","json":"https://worldwide-corruption.com/record/peru/findings/fcpa-pattern/W-03025/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB ~0.80' «CONSORCIO BRISTOL-MYERS SQUIBB PERU S.A. - PERUFARMA S.A. (+ more 6 legal entities of the family)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 8 non-competitive contracts at the buyer «CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD», 135,944,292 PEN (≈ $36,704,959); one bid, method direct (Contratación Directa), method direct (Exoneración); OCID ocds-dgv273-seacev3-955379, ocds-dgv273-seacev3-1025335, ocds-dgv273-seacev3-1066853, ocds-dgv273-seacev3-955395, ocds-dgv273-seacev3-1221063, ocds-dgv273-seacev3-1220947, ocds-dgv273-seacev3-1157685, ocds-dgv273-seacev3-44891; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","BMY · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","36,704,959",null],["Records behind the indicator","8",null],["Found","4 October 2026",null],["Code","W-03025",null],["Reference","ocds-dgv273-seacev3-955379",null],["Reference","ocds-dgv273-seacev3-1025335",null],["Reference","ocds-dgv273-seacev3-1066853",null],["Reference","ocds-dgv273-seacev3-955395",null],["Reference","ocds-dgv273-seacev3-1221063",null],["Reference","ocds-dgv273-seacev3-1220947",null],["Reference","ocds-dgv273-seacev3-1157685",null],["Reference","ocds-dgv273-seacev3-44891",null]],"summary":"looks like a subsidiary 'BRISTOL MYERS SQUIBB ~0.80' «CONSORCIO BRISTOL-MYERS SQUIBB PERU S.A. - PERUFARMA S.A. (+ more 6 legal entities of the family)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 8 non-competitive contracts at the buyer «CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD», 135,944,292 PEN (≈ $36,704,959); one bid, method direct (Contratación Directa), method direct (Exoneración); OCID ocds-dgv273-seacev3-955379, ocds-dgv273-seacev3-1025335, ocds-dgv273-seacev3-1066853, ocds-dgv273-seacev3-955395, ocds-dgv273-seacev3-1221063, ocds-dgv273-seacev3-1220947, ocds-dgv273-seacev3-1157685, ocds-dgv273-seacev3-44891; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"c46edf95"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Peru","iso2":"PE","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":523,"new_today":0,"on_pages":523,"full_list":[],"html":"https://worldwide-corruption.com/database/peru/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/peru/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/peru/findings/fcpa-pattern/W-03025/","json":"https://worldwide-corruption.com/record/peru/findings/fcpa-pattern/W-03025/index.json"}